Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Revvity, Inc. Common Stock (NY:RVTY)

96.21 -0.24 (-0.25%)
Streaming Delayed Price Updated: 10:12 AM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Revvity, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Revvity Analysts Increase Their Forecasts After Q3 Earnings
 
Via Benzinga
RVTY Q3 Deep Dive: AI Initiatives and Segment Divergence Shape Outlook
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $698.9 million. The company’s outlook for the full year was close to... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are moving in today's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
Revvity (RVTY) Stock Trades Down, Here Is Why
Shares of life sciences company Revvity (NYSE:RVTY) fell 2.4% in the afternoon session after it reported third-quarter financial results that showed a drop in profits and margins, even as revenue... 
Via StockStory
Topics Economy Government World Trade
Revvity Earnings Preview
 
Via Benzinga
What Analysts Are Saying About Revvity Stock
 
Via Benzinga
Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday?
Wall Street extended its record-setting streak on Monday, with major large-cap indices logging a third consecutive session of strong gains after a breakthrough in trade negotiations between Washington... 
Via Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends. 
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Monday?
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Is Revvity Gaining or Losing Market Support?
 
Via Benzinga
Revvity Lifts Profit Outlook, Launches $1 Billion Buyback Plan
Revvity Inc. (NYSE: RVTY) announced mixed Q3 results, beating EPS but missing revenue estimates, leading to a decline in stock price. 
Via Benzinga
Revvity Inc (NYSE:RVTY) Q3 2025 Earnings: EPS Beats Estimates, Revenue Falls Short
Revvity's Q3 2025 earnings beat EPS estimates but revenue was slightly below forecasts. The company announced a new $1 billion share buyback program. 
Via Chartmill
Topics Earnings
Revvity (NYSE:RVTY) Posts Q3 Sales In Line With Estimates
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $698.9 million. The company’s outlook for the full year was close to... 
Via StockStory
Revvity (RVTY) Q3 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be announcing earnings results this Monday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For October 27, 2025
 
Via Benzinga
What's Driving the Market Sentiment Around Revvity Inc?
 
Via Benzinga
Research Tools & Consumables Stocks Q2 Teardown: Revvity (NYSE:RVTY) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at research tools & consumables stocks,... 
Via StockStory
Topics Economy
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
Medpace and Revvity Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
1 Profitable Stock to Own for Decades and 2 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Topics Economy
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
Via MarketMinute
Topics Economy Government Supply Chain
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
1 Healthcare Stock with Exciting Potential and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
1 Oversold Stock Primed to Rebound and 2 We Brush Off
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
Topics Bonds
Discover which S&P500 stocks are making waves on Wednesday.
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Alphabet, Apple Fuel Tech Rebound, Gold Defies Gravity: What's Moving Markets Wednesday?
Wall Street staged a tentative rebound on Wednesday after two straight sessions of heavy tech losses, as rallies in Alphabet Inc. 
Via Benzinga
Revvity (RVTY) Stock Trades Down, Here Is Why
Shares of life sciences company Revvity (NYSE:RVTY) fell 5.1% in the afternoon session after several analyst firms lowered their price targets on the stock, pushing shares to a 52-week low. The... 
Via StockStory
Topics Bonds World Trade
Wednesday's session: top gainers and losers in the S&P500 index
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Wednesday as we examine the latest happenings in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.